Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial
AuthID
P-00Y-XM5
P-00Y-XM5
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service